Allergan (AGN), Nektar (NKTR) Shares Lower After Hours as Traders Wonder Where's the MAP (MAPP) News...

Article Stock Quotes (3) Comments (0)

Investors are still anxiously waiting for FDA news on MAP Pharma's (Nasdaq: MAPP) Levadex. As the stock was halted just ahead of 2pm ET, traders are using shares of partners Allergan (NYSE: AGN) and Nektar Therapeutics (Nasdaq: NKTR) as a way to play MAP. After closing at $7.87 this afternoon, Nektar shares are down about 3 percent to $7.62 after hours. Shares of Allergan, meanwhile, are down about 0.3 percent to $94.50.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Viropharma, Inc. (VPHM) Said to Attract Acquisition Interest - Reuters
• Mediabistro (MBIS) halted on circuit breaker; last up 82%
• Mediabistro (MBIS) Surges, But No One Knows Why

Create E-mail Alert Related Categories

FDA, Trader Talk

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?